BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30285929)

  • 1. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
    Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis.
    Lin RR; Warp PV; Maderal AD; Elman SA
    JAMA Dermatol; 2024 May; 160(5):575-577. PubMed ID: 38598206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
    Allenbach Y; Uzunhan Y; Toquet S; Leroux G; Gallay L; Marquet A; Meyer A; Guillaud C; Limal N; Gagnadoux F; Hervier B; Borie R; Deligny C; Terrier B; Berezne A; Audia S; Champtiaux N; Devilliers H; Voermans N; Diot E; Servettaz A; Marhadour T; Castelain V; Humbert S; Blanchard-Delaunay C; Tieulie N; Charles P; Gerin M; Mekinian A; Priou P; Meurice JC; Tazi A; Cottin V; Miyara M; Grange B; Israël-Biet D; Phin-Huynh S; Bron C; De Saint Martin L; Fabien N; Mariampillai K; Nunes H; Benveniste O;
    Neurology; 2020 Jul; 95(1):e70-e78. PubMed ID: 32487712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis Presenting as Refractory Gingivitis at the First Clinical Manifestation.
    Kawakami E; Uchida T; Iwamoto N; Hara K; Egashira K; Kawakami A
    Intern Med; 2024 Jan; 63(1):131-134. PubMed ID: 37197957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MDA5 dermatomyositis: an update from bench to bedside.
    Fuzzi E; Gatto M; Zen M; Franco C; Zanatta E; Ghirardello A; Doria A
    Curr Opin Rheumatol; 2022 Nov; 34(6):365-373. PubMed ID: 36094462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease.
    Witkowska AB; Cowley S; Dempsey P; Stack J
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives in the treatment of interstitial lung disease accompanied with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
    Tsuji H; Nakashima R; Mimori T
    Int J Rheum Dis; 2024 May; 27(5):e15201. PubMed ID: 38769940
    [No Abstract]   [Full Text] [Related]  

  • 8. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium.
    Figueiredo C; Matos AL; Calvao J; Goncalo M
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870
    [No Abstract]   [Full Text] [Related]  

  • 9. Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report.
    Pilia AM; Salvati L; Guidolin A; Mazzoni F; Antonuzzo L; Parronchi P; Liotta F
    Swiss Med Wkly; 2024 Mar; 154():3513. PubMed ID: 38579289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in a case of juvenile dermatomyositis with positive anti-melanoma differentiation associated protein 5 antibody.
    Kaplan MM; Çelikel E; Güngörer V; Ekici Tekin Z; Gürsu HA; Polat SE; Cinel G; Çelikel Acar B
    Int J Rheum Dis; 2023 Aug; 26(8):1582-1585. PubMed ID: 36852875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.
    Van Gompel E; Demirdal D; Fernandes-Cerqueira C; Horuluoglu B; Galindo-Feria A; Wigren E; Gräslund S; De Langhe E; Benveniste O; Notarnicola A; Chemin K; Lundberg IE
    Rheumatology (Oxford); 2024 May; 63(5):1466-1473. PubMed ID: 37572295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.
    Huang T; Ding T; Ding L; Xie S; Li X; Meng Q; Wu X; Luo H; Zhao H
    An Bras Dermatol; 2024; 99(3):342-349. PubMed ID: 38522973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction for Ichimura et al., Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2408646121. PubMed ID: 38776374
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature.
    Yamazaki S; Shimizu M; Yakabe A; Inage E; Jimbo K; Suzuki M; Miyaoka F; Kaneko S; Irabu H; Shimbo A; Ohtomo Y; Mori M; Morio T; Shimizu T
    Immunol Med; 2024 Jun; 47(2):110-117. PubMed ID: 38557269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.
    Chen C; Chen Y; Huang Q; Hu Q; Hong X
    Front Immunol; 2021; 12():625495. PubMed ID: 33717138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The central helicase domain holds the major conformational epitopes of melanoma differentiation-associated gene 5 autoantibodies.
    Mo Y; Ye Y; Peng L; Sun X; Zhong X; Wu R
    Rheumatology (Oxford); 2024 May; 63(5):1456-1465. PubMed ID: 37551942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China.
    Zhu H; Zhou W; Zheng L; Jiang Y; Lao Y; Li S; Jin M; Wang J; Li X
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated liver enzymes: unusual presentation of anti-MDA5 antibody-associated juvenile dermatomyositis.
    Yi BY; Marrs J; Schenker R; Suddock J; Cotter JA; Cidon M
    Clin Exp Rheumatol; 2024 Feb; 42(2):456-457. PubMed ID: 37279157
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful rescue treatment of refractory anti-MDA5 autoantibody positive dermatomyositis with rapidly progressive interstitial lung disease using daratumumab.
    Chua CG; Chai GT; Lim XR; Manghani M; Leung BPL; Koh LW
    Clin Exp Rheumatol; 2024 Feb; 42(2):460-461. PubMed ID: 38293965
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis.
    Ciaglia K; Ghawji M; Caraballo M; Sloan E
    Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38361479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.